Quick Reads es

While UN Agencies and Governments protest, and Gene Giants morph and maneuver, work on Terminator and Traitor Technologies goes full speed ahead. Genetic trait control technology is already being tested in the field. Can commercialization be far behind?

University of Georgia Refuses to Halt Project. Eleven indigenous peoples' organizations are demanding that a US$2.5 million, US-government funded bioprospecting program suspend its activities in Chiapas, Mexico. Despite the protest by local Mayan organizations, the University of Georgia (US) says it will not halt the five-year project, which aims to collect and evaluate thousands of plants and microorganisms used in traditional medicine by Mayan communities.Collectively known as the Council of Indigenous Traditional Midwives and Healers of Chiapas (Consejo Estatal de Parteras y M dicos Ind genas Tradicionales de Chiapas), the eleven Mayan organizations are denouncing the bioprospecting project, and they are asking other indigenous people in Chiapas to refuse to cooperate with the researchers. The project is led by the University of Georgia, in cooperation with a Mexican university research center, El Colegio de la Frontera Sur (ECOSUR), and Molecular Nature Ltd., a biotechnology company based in Wales, U.K. What is the Chiapas ICBG Project? The five-year project 'Drug Discovery and Biodiversity Among the Maya of Mexico,' now in its second year of operation, will receive a total grant of US$2.5 million dollars from the US government's International Cooperative Biodiversity Groups (ICBG). The ICBG is a consortium of US federal agencies, including the National Institutes of Health (NIH), the National Science Foundation (NSF) and the US Department of Agriculture (USDA) that awards grants to public and commercial research institutions that conduct bioprospecting/biopiracy programs in the South. The ICBG's self-stated goal is to promote drug discovery from natural sources, biodiversity conservation and sustainable economic growth in developing countries.

La negativa a rechazar las semillas suicidas podría significar que EE.UU. quiere utilizar "Terminator" como un "arma política" para imponer sus reglas de comercio. De Sanciones Comerciales a Sanciones Traidoras?

Monsanto surrenders 'suicide seeds' but continues work on other Traitor Technologies. With biotech's silver bullet firmly imbedded in its own foot, Monsanto is dropping its guns, abandoning the Terminator, and telling farmers that it wants to play nice. Not so fast, hombre! Following 18 months of controversy and intense popular opposition around the world, Monsanto CEO Robert B. Shapiro has advised Gordon Conway, President of the Rockefeller Foundation, that Monsanto has decided to abandon plans to commercialize Terminator Technology (causing crop seed to become sterile at harvest-time). Monsanto's open letter to Rockefeller is available on the company website at: www.monsanto.com/monsanto/gurt/default.htm (link no longer available) However, the company says it will continue to pursue closely related research targets that could allow Monsanto to switch on - or off - other genetic traits vital to a crop's productivity. RAFI calls it "Traitor" technology. "Congratulations should go to the civil society organizations, farmers, scientists, and governments all over the world who have waged highly effective anti-Terminator campaigns during the past 18 months," said Pat Mooney, Executive Director of RAFI, in reaction to Monsanto's announcement. "The public unanimously rejected Terminator because it's bad for farmers, food security, and the environment," explained Mooney. "Monsanto would never have abandoned the profit-generating potential of sterile seeds just because it was an immoral technology," said RAFI's Research Director, Hope Shand. "The company finally realized that Terminator will never win public acceptance. Terminator has became synonymous with corporate greed, and it was met with intense opposition all over the world," adds Shand.